Associate
Prior to joining Finnegan, Shannon worked for several years at the USPTO examining patent applications involving semiconductor technology, including chip packages, doping, electrostatic diffusion, etching, FinFETs, GAAs, HEMTs, implantation, interconnection structures, JFETs, magnetic devices, memory devices, MOSFETs, optoelectronics, photolithography, Schottky contacts, sensor packages, TFTs, and vertical FETs.
As a chemical engineer for Xerox, Shannon worked in the laboratories, the pilot plant, and the manufacturing plants to develop, analyze, and optimize designs and manufacturing processes for Xerographic Emulsion Aggregation chemical toners. Her research on chemical toners included the study of colloidal stability, surface ionization, triboelectric charge distribution, additive formulation, and optimization of particle size and circularity. Shannon presented her analyses on designed experiments to domestic and international management. She also developed specifications and manufacturing documentation for Xerographic toner products.
During her undergraduate studies, Shannon concentrated on biotechnology and biochemical engineering. Her undergraduate thesis detailed research on the design of a process to produce denosumab, a human monoclonal antibody for the treatment of osteoporosis and the prevention of skeleton-related events in patients with bone metastases from solid tumors, using single-use technology. Shannon also has experience using mathematical and computational tools for the analysis and simulation of chemical processes and physicochemical phenomena, having worked as an undergraduate teacher's assistant grader for the Modeling and Simulation in Chemical Engineering course at the University of Virginia.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.